Le Lézard
Classified in: Health
Subject: SVY

The human papillomavirus (HPV) therapeutics market will register a CAGR of nearly 9% by 2023


NEW YORK, Feb. 11, 2019 /PRNewswire/ -- About this market
Technological advances in diagnostics to drive market growth. The diagnostic methods that are currently available in the market include Pap test, colposcopy, and HPV DNA test. Pap test is a screening procedure for cervical cancer, in which the presence of precancerous or cancerous cells is identified on the cervix. Colposcopy is a more advanced technique like a Pap test, which allows the examiner to take abnormal cell tissues from the cervix. Technavio's analysts have predicted that the human papillomavirus (HPV) therapeutics market will register a CAGR of nearly 9% by 2023.

Read the full report: https://www.reportlinker.com/p05734222

Market Overview
Advent of vaccines
The global HPV therapeutics market witnessed strong advances in terms of prevention of diseases caused by HPV. This is primarily due to the increasing research on developing highly advanced vaccines with a longer half-life. Vaccines were proved to have strong efficacy toward the prevention of various disease-causing viruses and highly effective toward the prevention of various indications caused by HPV.
Multiple-dose schedules of vaccines
Despite the availability of vaccines for the prevention of indications caused by HPV, the market faces a challenge from their recurring doses. As the vaccines that are currently approved for HPV are developed for administering through invasive methods such as subcutaneous route, the need for multiple doses affects the patient adherence toward the completion of the dose cycle.
For the detailed list of factors that will drive and challenge the growth of the human papillomavirus (HPV) therapeutics market during the 2019-2023, view our report.

Competitive Landscape
The market appears to be fragmented and with the presence of several companies including ALLERGAN and Bausch Health the competitive environment is quite intense. Factors such as the advent of vaccines and the technological advances in diagnostics, will provide considerable growth opportunities to human papillomavirus (HPV) manufactures. ALLERGAN, Bausch Health, GlaxoSmithKline, Lee's Pharmaceutical Holdings, and Merck Sharp & Dohme are some of the major companies covered in this report.

Read the full report: https://www.reportlinker.com/p05734222

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

20 avr 2019
Dr. Noah Kaplan has recently earned a designation that qualifies him as a specialist in the health care field of the Cranio-Cervical Junction (head/neck). He is now one of about 40 doctors throughout the world, and only one in Northern California, to...

20 avr 2019
EmCare, Inc. and its affiliates (EmCare) today announced that they are addressing a data security incident that involved the personal information of some patients, employees and contractors. EmCare has launched an internal investigation, notified...

20 avr 2019
One of the hundreds of chemical compounds found in the cannabis plant, cannabidiol (CBD) consists of about 40 percent of cannabis extracts. Aside from being used in administering medical marijuana, CBD is also known for being infused in health and...

20 avr 2019
ADS Sports Eyewear ? a company specializing in prescription sports sunglasses, Oakley prescription sunglasses, prescription ski goggles, and pretty much anything eyewear related for active people ? will carry the latest releases from Oakley®...

20 avr 2019
Who hasn't heard of the term 420 and didn't have a mild giggle within? Everyone who uses cannabis or is familiar with cannabis culture knows about the 420 day and the importance it holds. But did you know how this terminology even came to be? It is...

19 avr 2019
Golden Pearl Mushrooms Ltd. is recalling GPM brand Pea Shoots from the marketplace due to possible Listeria monocytogenes contamination. Consumers should not consume the recalled products described below. The following products have been sold in...



News published on 11 february 2019 at 20:05 and distributed by: